Sheel Biotech IPO Listing at 44.44% premium at ₹91 Per Share

Wed Oct 08 2025

Click and Sign Up to Get Latest Updates on Sheel Biotech Limited

Sheel Biotech IPO Listing: The Sheel Biotech IPO was subscribed 15.97 times as of its closing. In this subscription, qualified institutional buyers (QIBs) received 19.73 times the allocation, and non-institutional investors (NIIs) received 25.92 times the allocation. The retail quota of the issue was subscribed to 33.41%. Before delving deeper into the topic, go through the details of the Sheel Biotech IPO.

Table of Contents

Sheel Biotech IPO Listing

On the NSE, shares are listed at ₹91 per share, representing a 44.44% premium over the issue price of ₹63.

Sheel Biotech IPO Details

It is a book-building IPO of ₹34.02 crores, comprising an entirely fresh issue of ₹0.54 crores. The problem will be listed on NSE and SME on its tentative listing date, 8th October 2025.

The Sheel Biotech IPO date is fixed between 30th September 2025 and 3rd October 2025. The face value of Sheel Biotech’s IPO shares is ₹10 per share, and the IPO price is set between ₹59 and ₹63 per share.

IPO Open Date	30th September 2025
IPO Close Date	3rd October 2025
IPO Allotment Date	6th October 2025
Refund Initiation	7th October 2025
Issue Size	54,00,000 shares(aggregating up to ₹34.02 Cr)
Face Value	₹10 per share
Lot Size	1,600 shares
Issue Price Final	₹129 and ₹136 per share
Issue Type	Bookbuilding IPO
Listing At	NSE & SME
Listing Date	8th October 2025

About Sheel Biotech Limited

Sheel Biotech Limited was established in November 1991. Sheel Biotech Limited specialises in biotechnology, floriculture, greenhouses, and organic projects. The company grows and supplies various plants for field crops, fruits, vegetables, and ornamentals through tissue culture and organic farming. The company manufactures and maintains greenhouses, provides farmer services, and offers training through FPOs. They also deliver landscaping services to the government and private sectors. The company holds ISO 9001:2015, 14001:2015, and 45001:2018 certifications, reflecting its commitment to quality, environmental responsibility, and safety. The company’s Research and Development laboratory is recognised by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST) of the Government of India.

Sheel Biotech Limited Financials

The company’s financial analysis is essential before applying for the Sheel Biotech IPO. Refer to the table to learn about Sheel Biotech Limited’s financial information.

Year Ended	31st March 2024 (in cr.)	31st March 2023 (in cr.)	31st March 2022 (in cr.)
Assets	105.95	93.99	93.08
Revenue	92.55	80.19	71.07
Profit After Tax	10.51	5.08	4.51
Net Worth	72.73	63.54	59.75
EBITDA	–	–	–
Reserve and Surplus	68.58	59.4	55.61
Total Borrowing	23.54	19.17	23.58

Explanation

Sheel Biotech Limited’s revenue increased by 15.41% from ₹80.19 crore in March 2023 to ₹ 92.55 crore in March 2024. Moreover, the company’s PAT rose by 106.89% from ₹5.08 crores to ₹10.51 crores.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!